1. Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy
   Terrence Wong et al, 2023, Seminars in Respiratory and Critical Care Medicine CrossRef
2. Endostatin Level is Associated with Kidney Injury in the Elderly: Findings from Two Community-Based Cohorts
   Toralph Ruge et al, 2014, American Journal of Nephrology CrossRef
3. Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys
   Lifang Guo et al, 2014, Regulatory Toxicology and Pharmacology CrossRef
4. Malignant pleural disease
   Laura M. Piggott et al, 2023, Breathe CrossRef
5. Endostar, a novel human recombinant endostatin, attenuates liver fibrosis in CCl4-induced mice
   Jing Chen et al, 2014, Experimental Biology and Medicine CrossRef
6. Influence of different drug delivery methods for Endostar combined with a gemcitabine/cisplatin regimen in locally advanced or metastatic lung squamous cell carcinoma
   Difei Yao et al, 2018, Medicine CrossRef
7. Quality, bioactivity study, and preclinical acute toxicity, safety pharmacology evaluation of PEGylated recombinant human endostatin (M2ES)
   Lifang Guo et al, 2019, Journal of Biochemical and Molecular Toxicology CrossRef
8. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies
   Bo Wang et al, 2020, BMC Cancer CrossRef
9. Endocultivation: continuous application of rhBMP-2 via mini-osmotic pumps to induce bone formation at extraskeletal sites
   B.E. Beck-Broichsitter et al, 2017, International Journal of Oral and Maxillofacial Surgery CrossRef
10. Contrast-enhanced ultrasound analysis of tissue perfusion in tumor-bearing mice following treatment with endostatin combined with radiotherapy
    WEI GE et al, 2014, Experimental and Therapeutic Medicine CrossRef